Medtronic (MDT) Tops Q3 EPS by 3c; Bumps Guidance Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Medtronic reports third quarter fiscal 2023 financial results
February 21, 2023 6:45 AM ESTDelivers top and bottom line ahead of expectations, with strength in Cardiovascular and Neuroscience portfolios
DUBLIN, Feb. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2023, which ended January 27, 2023.
Key Highlights
Revenue of $7.7 billion was flat as reported and increased 4.1% organic, ahead of expectationsGAAP diluted EPS of $0.92 decreased 16%; non-GAAP diluted EPS of... More